Adnan Chhatriwalla, MD
Interventional Cardiology · Kansas City, MONPI 1508035163
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (33.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 56.4% of the total. Among interventional cardiology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 489 payments — averaging $232.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$64K
- Edwards Lifesciences$31K
- Abbott$14K
- Boston Scientific$3K
- Biotronik Inc.$251
- Biocardia, Inc.$245
- plus $1K from 12 others
Across 407 payments — averaging $8669.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$3.3M
- Abbott$117K
- Boston Scientific$82K
- Medtronic$19K
- Bayer$8K
What the payments were for
- Consulting fees$15,88114%
- Speaking & faculty fees$36,00032%
- Travel & lodging$38,46634%
- Food & beverage$23,11820%
- Education$200%
- Entertainment$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 205 | $64,043 |
| Edwards Lifesciences | 157 | $31,248 |
| Abbott | 86 | $14,156 |
| Boston Scientific | 18 | $2,571 |
| Biotronik Inc. | 6 | $251 |
| Biocardia, Inc. | 2 | $245 |
| Siemens Medical Solutions USA, Inc. | 3 | $240 |
| Silk Road Medical, Inc. | 1 | $165 |
| Teleflex LLC | 2 | $162 |
| Asahi Intecc USA, Inc. | 1 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $99 |
| Abiomed | 1 | $81 |
| Shockwave Medical, Inc | 1 | $65 |
| Opsens Inc. | 1 | $34 |
| CSL Behring | 1 | $20 |
| Merit Medical Systems Inc | 1 | $18 |
| Arrow International, Inc. | 1 | $14 |
| Penumbra, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$31,025
- COREVALVE EVOLUT R$24,593
- Edwards SAPIEN 3 Transcatheter Heart Valve$16,971
- NAVITOR$6,265
- AMPLATZER AMULET$2,000
- EVOQUE$1,801
- PASCAL$1,580
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,357
- GENERAL - THERAPIES$1,200
- SAPIEN 3 Ultra RESILIA$1,078
- MitraClip$1,030
- AMPLATZER Occluders$507
- RESOLUTE ONYX$465
- Mitra Clip system$447
- Watchman$270
- LOTUS EDGE$246
- Octopus$210
- XIENCE SIERRA$177
- ENROUTE Transcarotid Neuroprotection System$165
- ENROUTE Transcarotid Stent System$165
How this compares
$113,519 in reported general payments places this provider in the 90th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $70,698 |
| EntrestoSacubitril/Valsartan | 29 | $20,714 |
| Praluent PenAlirocumab | 14 | $7,091 |
| Repatha SureclickEvolocumab | 13 | $7,081 |
| Atorvastatin Calcium | 118 | $1,919 |
| Metoprolol Succinate | 114 | $1,248 |
| Carvedilol | 101 | $1,047 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 32 | $838 |
| Rosuvastatin Calcium | 53 | $727 |
| Digoxin | 22 | $647 |
| ClopidogrelClopidogrel Bisulfate | 41 | $595 |
| Losartan Potassium | 56 | $594 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 20 | $560 |
| Warfarin Sodium | 53 | $519 |
| Ezetimibe | 29 | $488 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Kansas City
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Kenneth HuberKansas City$110K
- Chetan HudedKansas City$61K
- Adam SalisburyKansas City$52K
- Steven MarsoKansas City$42K
- Dany JacobKansas City$35K
- Muhammad Anis HaiderKansas City$35K
- Francisco LammogliaKansas City$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.